Results 41 to 50 of about 1,148 (137)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.

PLoS ONE, 2017
BackgroundSubstandard and falsified medical products present a serious threat to public health, especially in low- and middle-income countries. Their identification using pharmacopeial analysis is expensive and requires sophisticated equipment and highly
Albert Petersen, Nadja Held, Lutz Heide, Difäm-EPN Minilab Survey Group   +3 more
doaj   +1 more source

A Literature Review on the Global Burden and Impact of Substandard and Falsified Medicine

Annals of Public Health Issues, 2022
Abstract Substandard and falsified medicines are a global health concern negatively affecting individuals, the public, the pharmaceutical industry and governments all over the world. This review aims to examine the global prevalence of substandard and falsified medicines, its impact on health and the health system, including socio ...
Olanrewaju Olamide Popoola, Gulshan Madhur, Mariam Medhat Mehrim, Mark Odhiambo Omondi, Priscilla Owusu-Mensah, Saurabh Ashok Mamtani, Alison Ubong Etukakpan   +6 more
openaire   +1 more source

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review

Journal of Pharmaceutical Policy and Practice
Background: Substandard, falsified, unlicensed, and unregistered medicines pose significant risks to public health in developed and developing countries. This systematic review provides an overview of the prevalence of substandard, falsified, unlicensed,
Biset Asrade Mekonnen, Muluabay Getie Yizengaw, Minichil Chanie Worku   +2 more
doaj   +1 more source

Quality of medicines in southern Togo: Investigation of antibiotics and of medicines for non-communicable diseases from pharmacies and informal vendors.

PLoS ONE, 2018
Substandard and falsified medicines represent a serious threat for public health and patient safety. Especially in low and middle-income countries, the prevalence of substandard and falsified medicines is reportedly high. However, reliable information on
Simon Schäfermann, Emmanuel Wemakor, Cathrin Hauk, Lutz Heide   +3 more
doaj   +1 more source

Technologies for detecting falsified and substandard drugs in low and middle-income countries. [PDF]

PLoS ONE, 2014
Falsified and substandard drugs are a global health problem, particularly in low- and middle-income countries (LMIC) that have weak pharmacovigilance and drug regulatory systems.
Stephanie Kovacs, Stephen E Hawes, Stephen N Maley, Emily Mosites, Ling Wong, Andy Stergachis   +5 more
doaj   +1 more source

Advancing health system strengthening through improving access to medicines: A review of local manufacturing policies in Ghana

Medicine Access @ Point of Care, 2020
Providing access to quality-assured medicines is a fundamental component of strengthening health systems. Yet, the World Health Organization (WHO) estimates that 13.6% of all medicines in low- and middle-income countries (LMIC’s) may be substandard or ...
Kwame Peprah Boaitey, Chloe Tuck
doaj   +1 more source

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model

BMC Public Health, 2020
Background Many countries are striving to become malaria-free, but global reduction in case estimates has stagnated in recent years. Substandard and falsified medicines may contribute to this lack of progress. Zambia aims to eliminate their annual burden
Kathryn D. Jackson, Colleen R. Higgins, Sarah K. Laing, Chiluba Mwila, Tamaki Kobayashi, Matthew M. Ippolito, Sean Sylvia, Sachiko Ozawa   +7 more
doaj   +1 more source

Consigning Injustice to History with Political Apologies

Journal of Applied Philosophy, EarlyView.
ABSTRACT Failures to remember the past properly can constitute a range of different wrongs. In this article, we identify a novel kind of wrong that often occurs through political apologies: consigning an injustice to history. Consigning acknowledges that a historical injustice took place but denies that it has any ongoing relevance for the present ...
Alfred Archer, Benjamin Matheson
wiley   +1 more source

The Role of Pharmacists in Tackling Mpox: Challenges and Future Prospects: A Narrative Review

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Pharmacists play a key role in managing and mitigating mpox through clinical care, pharmacovigilance, vaccine management, and resilient supply chains. Management focuses on supportive care, infection prevention, and accurate diagnosis, with pharmacists ensuring the availability and rational use of vaccines, disinfectants ...
Ayalew Sirbemo Degebo, Fisseha Assegidew Gebretsadik, Abyou Seyfu Ambaye, Bedilu Linger Endalifer, Teshome Fentik Belachew   +4 more
wiley   +1 more source

The Challenges of Scientific Publishing: An Editor‐In‐Chief's Perspective

Fundamental &Clinical Pharmacology, Volume 40, Issue 4, July 2026.
ABSTRACT The current and former editors‐in‐chief of the Fundamental & Clinical Pharmacology journal share their experience and perspectives regarding the present landscape of scientific publishing and the challenges and threats it faces. Several challenges are identified, three of which are of particular significance.
Luc Zimmer, Pascal Bousquet
wiley   +1 more source